Oruka Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.9% | -37.9% | -35.2% |
| FY2022 | -23.8% | -23.8% | -23.0% |
| FY2023 | -14.4% | -14.4% | -14.1% |
| FY2024 | -21.9% | -21.9% | -21.1% |
| FY2025 | -22.3% | -22.3% | -21.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.9% | -37.9% | -35.2% |
| FY2022 | -23.8% | -23.8% | -23.0% |
| FY2023 | -14.4% | -14.4% | -14.1% |
| FY2024 | -21.9% | -21.9% | -21.1% |
| FY2025 | -22.3% | -22.3% | -21.6% |